May 1-5, 2017
PEGS Summit 2017
Seaport World Trade Center • Boston, MA
DiscoverX booth #432
Podium Presentation—Wednesday, May 3, 3:15–3:30 p.m.
Enabling Technologies for Development and Optimization of Bi-Specific Antibodies for T-Cell Redirection
Presenter: Jane Lamerdin, Ph.D.
- Novel, Improved Cell-based Assays to Enable Immunotherapy Drug Development for Checkpoint Receptors
- Robust and Reproducible ADCC and T-Cell Redirection with CD-16-engineered Effector Cells
- Immune Checkpoint Inhibitor Profiling and Biomarker Identification Using Human Primary Cell BioMAP® Oncology Systems